Louisiana State University
Henry Ford Health System
How it works
Proteomics + clinical data
You provide a few key clinical data elements, we provide 5,000 highly reproducible measurements for each sample
Supporting Your Research
The SomaScan Platform provides, by far, the most comprehensive picture of the human proteome available to date
Furthering our mission
To deliver health and wellness information that ensures future patient access to emerging therapies
SAME GENOTYPE. DIFFERENT PHENOTYPE.
PROTEIN ASSAYS COMPLEMENT GENOMICS TO IDENTIFY:
- Patient subpopulations
- Novel therapeutic targets
- New disease applications for approved drugs
- Possible safety concerns
- Mechanisms of action
key disease areas
Identify and characterize cancers and predict response to immunotherapy by measuring circulating proteins.
The SomaScan platform is optimized for clinical proteomics
The largest commercial proteomic assay on the market, providing over 5,000 protein measurements.
Our workflow is massively multiplexed with considerable controls to yield fast, accurate data.
LOWEST Coefficient of variation
With average CVs of <5%, SomaScan reagents provide reproducible results for patient samples and healthy controls.
8 log dynamic range
Our unique approach detects very rare proteins and highly abundant proteins from the same sample simultaneously.
liquid health check
Protein signatures from 17,000 samples were compared with traditional health indicators to generate 13 predictive models.
Circulating proteins were used to identify 27 network modules associated with CVD, metabolic diseases, and overall survival.